Teladoc Health Q2 EPS $(0.40) Beats $(0.41) Estimate, Sales $652.40M Beat $649.19M Estimate
Portfolio Pulse from Benzinga Newsdesk
Teladoc Health reported Q2 earnings per share of $(0.40), beating the analyst consensus estimate of $(0.41) by 2.44%. The company also reported quarterly sales of $652.40 million, surpassing the analyst consensus estimate of $649.19 million by 0.49%. Both earnings and sales have increased compared to the same period last year.
July 25, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Teladoc Health's Q2 earnings and sales beat analyst estimates, indicating a positive financial performance. This could potentially lead to a short-term increase in the company's stock price.
Teladoc Health's better-than-expected Q2 earnings and sales indicate a strong financial performance. This positive news is likely to increase investor confidence, potentially leading to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100